Search research articles
Contact Us
Filters
Showing results (721-730 of 845) with videos related to
Page
of 85
Sort By:
Open Forum Infectious Diseases
|
July 22, 2017
Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study
Sara Tomczyk, Seema Jain, Anna M Bramley, et al.
Vaccine
|
May 19, 2009
CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus
Nadezhda E Yun, Bi-Hung Peng, Andrea S Bertke, et al.
Plos One
|
May 22, 2013
A humanized mouse model of tuberculosis
Veronica E Calderon, Gustavo Valbuena, Yenny Goez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 11, 2019
Sacubitril/Valsartan Augments Postprandial Plasma Concentrations of Active GLP-1 When Combined With Sitagliptin in Men
Nicolai J Wewer Albrechtsen, Peter D Mark, Dijana Terzic, et al.
Vaccine
|
September 15, 2010
Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis
Sarah A Ngugi, Valeria V Ventura, Omar Qazi, et al.
British Journal of Cancer
|
December 21, 2006
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China
F Kamangar, Y-L Qiao, M J Blaser, et al.
The American Journal of Emergency Medicine
|
March 15, 2015
Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath
Frances M Russell, Christopher L Moore, D Mark Courtney, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 21, 2014
Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles
Diana L Castillo-Carranza, Urmi Sengupta, Marcos J Guerrero-Muñoz, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors
Bernard Barlaam, Judith Anderton, Peter Ballard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer
D Mark Hickinson, Teresa Klinowska, Georgina Speake, et al.
Page
of 85
Search research articles
Search
Showing results (721-730 of 845) with videos related to
Sort By:
Page
of 85
Open Forum Infectious Diseases
|
July 22, 2017
Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study
Sara Tomczyk, Seema Jain, Anna M Bramley, et al.
Vaccine
|
May 19, 2009
CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus
Nadezhda E Yun, Bi-Hung Peng, Andrea S Bertke, et al.
Plos One
|
May 22, 2013
A humanized mouse model of tuberculosis
Veronica E Calderon, Gustavo Valbuena, Yenny Goez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 11, 2019
Sacubitril/Valsartan Augments Postprandial Plasma Concentrations of Active GLP-1 When Combined With Sitagliptin in Men
Nicolai J Wewer Albrechtsen, Peter D Mark, Dijana Terzic, et al.
Vaccine
|
September 15, 2010
Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis
Sarah A Ngugi, Valeria V Ventura, Omar Qazi, et al.
British Journal of Cancer
|
December 21, 2006
Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China
F Kamangar, Y-L Qiao, M J Blaser, et al.
The American Journal of Emergency Medicine
|
March 15, 2015
Independent evaluation of a simple clinical prediction rule to identify right ventricular dysfunction in patients with shortness of breath
Frances M Russell, Christopher L Moore, D Mark Courtney, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 21, 2014
Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles
Diana L Castillo-Carranza, Urmi Sengupta, Marcos J Guerrero-Muñoz, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors
Bernard Barlaam, Judith Anderton, Peter Ballard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer
D Mark Hickinson, Teresa Klinowska, Georgina Speake, et al.
Page
of 85